查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867547

微針給藥系統：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Microneedle Drug Delivery Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球微針藥物輸送系統市場規模估計為 5.12 億美元，預計到 2031 年將達到 13.35 億美元，在預測期（2025-2031 年）內複合年成長率為 15.2%。

微針給藥系統是一種創新且無痛的給藥技術，它透過微米級針頭穿透皮膚表層，精準地將藥物輸送至目標部位。該系統結合了微納加工技術和控釋技術，能夠有效地遞送疫苗、生物製藥、小分子藥物等，顯著提高藥物的生物利用度和患者依從性。與傳統注射相比，微針系統可減輕疼痛並降低交叉感染的風險，從而實現自我給藥和大規模疫苗宣傳活動。隨著個人化醫療和智慧醫療設備的興起，微針給藥系統在慢性病管理、疫苗接種和美容醫學領域展現出巨大的潛力，有望成為推動醫療創新的重要力量。

微針給藥系統市場主要受兩大驅動力推動：全球醫療需求的成長和技術進步。疫苗接種量的激增，尤其是在公共衛生措施和疫苗接種計劃的推動下，加速了無痛高效給藥技術的應用。製藥和醫療設備製造商正加大研發投入，以實現產品多元化並拓展應用範圍。政策對創新給藥技術的支持以及患者對非侵入性治療的偏好，共同推動了市場強勁成長。此外，向慢性病管理和美容醫學等新興領域的拓展也顯著提升了市場潛力。儘管前景廣闊，微針給藥系統仍面臨許多挑戰。技術複雜性和高昂的製造成本限制了其大規模商業化。藥物與材料的相容性問題，以及給藥效率和劑量控制穩定性等問題，仍需進一步最佳化。冗長的監管核准流程和各國標準的不統一，也阻礙了其全球擴張。市場對安全性和長期療效的日益關注，要求品管和臨床檢驗持續改善。教育程度和患者接受度也顯著影響市場滲透率。下游需求正朝著多元化和個人化方向發展。隨著數位醫療和遠端醫療的發展，微針系統正日益整合智慧監測和數據分析功能，以提高治療精準度和病患體驗。疫苗和生物製藥的快速供應需求推動了物流和供應鏈管理的創新。在慢性病管理領域，微針系統可實現便利的自我給藥和療效監測。美容醫療市場對安全、無痛、微創解決方案的持續需求，推動了產品創新和市場擴張。整體而言，下游需求正從單一的給藥功能整合到一體化的健康管理平台。

本報告旨在按地區/國家、類型和應用對全球微針藥物輸送系統市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，對微針給藥系統市場規模、估算和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定微針給藥系統業務和成長策略，評估市場競爭情況，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson（BD）Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

按類型分類的細分市場

  • 中空微針技術
  • 固體微針技術
  • 溶解性微針技術

應用領域

  • 藥物輸送
  • 疫苗接種

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Microneedle Drug Delivery Systems was estimated to be worth US$ 512 million in 2024 and is forecast to a readjusted size of US$ 1335 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.

Microneedle Drug Delivery Systems represent an innovative and painless drug administration technology that delivers medication precisely through micron-scale needles penetrating the skin's outer layer. Combining micro-nanofabrication and controlled drug release technologies, these systems efficiently deliver vaccines, biologics, small molecule drugs, and more, significantly enhancing drug bioavailability and patient compliance. Compared to conventional injections, microneedle systems reduce pain and the risk of cross-contamination, enabling self-administration and large-scale immunization campaigns. With the rise of personalized medicine and smart healthcare devices, microneedle drug delivery systems show vast potential in chronic disease management, vaccination, and aesthetic medicine, positioning themselves as a key driver of medical innovation.

The microneedle drug delivery systems market benefits from the dual drivers of rising global healthcare demands and technological advancements. The surge in vaccine administration, especially driven by public health initiatives and immunization programs, accelerates the adoption of painless and efficient delivery technologies. Pharmaceutical companies and medical device manufacturers increase R&D investments to diversify products and expand applications. Policy support for innovative drug delivery technologies and patient preference for non-invasive treatments inject strong growth momentum. Additionally, penetration into emerging fields like chronic disease management and aesthetic medicine significantly broadens market potential.Despite promising prospects, microneedle drug delivery systems face multiple challenges. Technical complexity and high manufacturing costs limit large-scale commercialization. Compatibility issues between drugs and materials, as well as stability in delivery efficiency and dosage control, require further optimization. Regulatory approval processes are lengthy, and inconsistent standards across countries increase difficulties in global product rollout. Rising market concerns over safety and long-term efficacy demand continuous improvements in quality control and clinical validation. Education and patient acceptance also critically affect market penetration.Downstream demand is moving toward diversification and personalization. With the development of digital health and telemedicine, microneedle systems increasingly integrate intelligent monitoring and data analytics to enhance treatment precision and patient experience. The rapid delivery needs of vaccines and biologics drive innovations in logistics and supply chain management. In chronic disease management, microneedle systems offer convenient self-administration and efficacy monitoring. The aesthetic medicine market's ongoing demand for safe and painless minimally invasive solutions propels product innovation and market expansion. Overall, downstream demand is evolving from single delivery functions to integrated health management platforms.

This report aims to provide a comprehensive presentation of the global market for Microneedle Drug Delivery Systems, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microneedle Drug Delivery Systems by region & country, by Type, and by Application.

The Microneedle Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Drug Delivery Systems.

Market Segmentation

By Company

  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

Segment by Type

  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology

Segment by Application

  • Drug Delivery
  • Vaccine Delivery

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Microneedle Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Microneedle Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Microneedle Drug Delivery Systems in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Microneedle Drug Delivery Systems Product Introduction
  • 1.2 Global Microneedle Drug Delivery Systems Market Size Forecast (2020-2031)
  • 1.3 Microneedle Drug Delivery Systems Market Trends & Drivers
    • 1.3.1 Microneedle Drug Delivery Systems Industry Trends
    • 1.3.2 Microneedle Drug Delivery Systems Market Drivers & Opportunity
    • 1.3.3 Microneedle Drug Delivery Systems Market Challenges
    • 1.3.4 Microneedle Drug Delivery Systems Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Microneedle Drug Delivery Systems Players Revenue Ranking (2024)
  • 2.2 Global Microneedle Drug Delivery Systems Revenue by Company (2020-2025)
  • 2.3 Key Companies Microneedle Drug Delivery Systems Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Microneedle Drug Delivery Systems Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Microneedle Drug Delivery Systems
  • 2.6 Microneedle Drug Delivery Systems Market Competitive Analysis
    • 2.6.1 Microneedle Drug Delivery Systems Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Microneedle Drug Delivery Systems Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Drug Delivery Systems as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Hollow Microneedle Technology
    • 3.1.2 Solid Microneedle Technology
    • 3.1.3 Dissolving Microneedles Technology
  • 3.2 Global Microneedle Drug Delivery Systems Sales Value by Type
    • 3.2.1 Global Microneedle Drug Delivery Systems Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Microneedle Drug Delivery Systems Sales Value, by Type (2020-2031)
    • 3.2.3 Global Microneedle Drug Delivery Systems Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Drug Delivery
    • 4.1.2 Vaccine Delivery
  • 4.2 Global Microneedle Drug Delivery Systems Sales Value by Application
    • 4.2.1 Global Microneedle Drug Delivery Systems Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Microneedle Drug Delivery Systems Sales Value, by Application (2020-2031)
    • 4.2.3 Global Microneedle Drug Delivery Systems Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Microneedle Drug Delivery Systems Sales Value by Region
    • 5.1.1 Global Microneedle Drug Delivery Systems Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025)
    • 5.1.3 Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031)
    • 5.1.4 Global Microneedle Drug Delivery Systems Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.2.2 North America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.3.2 Europe Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Microneedle Drug Delivery Systems Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.5.2 South America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Microneedle Drug Delivery Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.3.2 United States Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.4.2 Europe Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.5.2 China Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.6.2 Japan Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.7.2 South Korea Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.9.2 India Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 KINDEVA
    • 7.1.1 KINDEVA Profile
    • 7.1.2 KINDEVA Main Business
    • 7.1.3 KINDEVA Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.1.4 KINDEVA Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.1.5 KINDEVA Recent Developments
  • 7.2 Zosano Pharma
    • 7.2.1 Zosano Pharma Profile
    • 7.2.2 Zosano Pharma Main Business
    • 7.2.3 Zosano Pharma Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.2.4 Zosano Pharma Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Zosano Pharma Recent Developments
  • 7.3 Becton-Dickinson(BD)Technologies
    • 7.3.1 Becton-Dickinson(BD)Technologies Profile
    • 7.3.2 Becton-Dickinson(BD)Technologies Main Business
    • 7.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  • 7.4 Nanopass Technologies
    • 7.4.1 Nanopass Technologies Profile
    • 7.4.2 Nanopass Technologies Main Business
    • 7.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Nanopass Technologies Recent Developments
  • 7.5 Corium
    • 7.5.1 Corium Profile
    • 7.5.2 Corium Main Business
    • 7.5.3 Corium Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.5.4 Corium Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Corium Recent Developments
  • 7.6 Valeritas
    • 7.6.1 Valeritas Profile
    • 7.6.2 Valeritas Main Business
    • 7.6.3 Valeritas Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.6.4 Valeritas Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Valeritas Recent Developments
  • 7.7 Nitto
    • 7.7.1 Nitto Profile
    • 7.7.2 Nitto Main Business
    • 7.7.3 Nitto Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.7.4 Nitto Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Nitto Recent Developments
  • 7.8 Microdermics
    • 7.8.1 Microdermics Profile
    • 7.8.2 Microdermics Main Business
    • 7.8.3 Microdermics Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.8.4 Microdermics Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Microdermics Recent Developments
  • 7.9 TheraJect, Inc
    • 7.9.1 TheraJect, Inc Profile
    • 7.9.2 TheraJect, Inc Main Business
    • 7.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.9.5 TheraJect, Inc Recent Developments
  • 7.10 Vaxxas
    • 7.10.1 Vaxxas Profile
    • 7.10.2 Vaxxas Main Business
    • 7.10.3 Vaxxas Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.10.4 Vaxxas Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Vaxxas Recent Developments
  • 7.11 Lohmann Therapie-Systeme AG
    • 7.11.1 Lohmann Therapie-Systeme AG Profile
    • 7.11.2 Lohmann Therapie-Systeme AG Main Business
    • 7.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Lohmann Therapie-Systeme AG Recent Developments

8 Industry Chain Analysis

  • 8.1 Microneedle Drug Delivery Systems Industrial Chain
  • 8.2 Microneedle Drug Delivery Systems Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Microneedle Drug Delivery Systems Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Microneedle Drug Delivery Systems Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Microneedle Drug Delivery Systems Market Trends
  • Table 2. Microneedle Drug Delivery Systems Market Drivers & Opportunity
  • Table 3. Microneedle Drug Delivery Systems Market Challenges
  • Table 4. Microneedle Drug Delivery Systems Market Restraints
  • Table 5. Global Microneedle Drug Delivery Systems Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Microneedle Drug Delivery Systems Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Microneedle Drug Delivery Systems Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Microneedle Drug Delivery Systems Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Microneedle Drug Delivery Systems
  • Table 10. Global Microneedle Drug Delivery Systems Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Drug Delivery Systems as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Microneedle Drug Delivery Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Microneedle Drug Delivery Systems Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Microneedle Drug Delivery Systems Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Microneedle Drug Delivery Systems Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Microneedle Drug Delivery Systems Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Microneedle Drug Delivery Systems Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Microneedle Drug Delivery Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, (2026-2031) & (US$ Million)
  • Table 31. KINDEVA Basic Information List
  • Table 32. KINDEVA Description and Business Overview
  • Table 33. KINDEVA Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of KINDEVA (2020-2025)
  • Table 35. KINDEVA Recent Developments
  • Table 36. Zosano Pharma Basic Information List
  • Table 37. Zosano Pharma Description and Business Overview
  • Table 38. Zosano Pharma Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Zosano Pharma (2020-2025)
  • Table 40. Zosano Pharma Recent Developments
  • Table 41. Becton-Dickinson(BD)Technologies Basic Information List
  • Table 42. Becton-Dickinson(BD)Technologies Description and Business Overview
  • Table 43. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Becton-Dickinson(BD)Technologies (2020-2025)
  • Table 45. Becton-Dickinson(BD)Technologies Recent Developments
  • Table 46. Nanopass Technologies Basic Information List
  • Table 47. Nanopass Technologies Description and Business Overview
  • Table 48. Nanopass Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Nanopass Technologies (2020-2025)
  • Table 50. Nanopass Technologies Recent Developments
  • Table 51. Corium Basic Information List
  • Table 52. Corium Description and Business Overview
  • Table 53. Corium Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Corium (2020-2025)
  • Table 55. Corium Recent Developments
  • Table 56. Valeritas Basic Information List
  • Table 57. Valeritas Description and Business Overview
  • Table 58. Valeritas Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Valeritas (2020-2025)
  • Table 60. Valeritas Recent Developments
  • Table 61. Nitto Basic Information List
  • Table 62. Nitto Description and Business Overview
  • Table 63. Nitto Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Nitto (2020-2025)
  • Table 65. Nitto Recent Developments
  • Table 66. Microdermics Basic Information List
  • Table 67. Microdermics Description and Business Overview
  • Table 68. Microdermics Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Microdermics (2020-2025)
  • Table 70. Microdermics Recent Developments
  • Table 71. TheraJect, Inc Basic Information List
  • Table 72. TheraJect, Inc Description and Business Overview
  • Table 73. TheraJect, Inc Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of TheraJect, Inc (2020-2025)
  • Table 75. TheraJect, Inc Recent Developments
  • Table 76. Vaxxas Basic Information List
  • Table 77. Vaxxas Description and Business Overview
  • Table 78. Vaxxas Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Vaxxas (2020-2025)
  • Table 80. Vaxxas Recent Developments
  • Table 81. Lohmann Therapie-Systeme AG Basic Information List
  • Table 82. Lohmann Therapie-Systeme AG Description and Business Overview
  • Table 83. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Lohmann Therapie-Systeme AG (2020-2025)
  • Table 85. Lohmann Therapie-Systeme AG Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Microneedle Drug Delivery Systems Downstream Customers
  • Table 89. Microneedle Drug Delivery Systems Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Microneedle Drug Delivery Systems Product Picture
  • Figure 2. Global Microneedle Drug Delivery Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Microneedle Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Microneedle Drug Delivery Systems Report Years Considered
  • Figure 5. Global Microneedle Drug Delivery Systems Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Microneedle Drug Delivery Systems Revenue in 2024
  • Figure 7. Microneedle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Hollow Microneedle Technology Picture
  • Figure 9. Solid Microneedle Technology Picture
  • Figure 10. Dissolving Microneedles Technology Picture
  • Figure 11. Global Microneedle Drug Delivery Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Microneedle Drug Delivery Systems Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Drug Delivery
  • Figure 14. Product Picture of Vaccine Delivery
  • Figure 15. Global Microneedle Drug Delivery Systems Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Microneedle Drug Delivery Systems Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Microneedle Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Microneedle Drug Delivery Systems Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value (%), (2020-2031)
  • Figure 28. United States Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Microneedle Drug Delivery Systems Industrial Chain
  • Figure 50. Microneedle Drug Delivery Systems Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed